Concepedia

Krzysztof Marciniec

KM

Statistics

Publications

27

Citations

860

H-Index

19

Active since

2007

Affiliations

Medical University of Silesia(Current)

Polish Academy of Sciences

University of Silesia in Katowice

Jagiellonian University

Maj Institute of Pharmacology

Krzysztof Marciniec is an author at Medical University of Silesia specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2007–2023

27

Publications

27

Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors

Paweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz et al. · European Journal of Medicinal Chemistry · 2012 · 110 citations · Full text

, , +16

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis

Krzysztof Marciniec, Artur Beberok, Paweł Pęcak et al. · Pharmacological Reports · 2020 · 79 citations · Full text

, , +17

Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation

Paweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz et al. · Bioorganic & Medicinal Chemistry · 2012 · 69 citations · Full text

, , +17

Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone

Monika Kadela-Tomanek, Maria Jastrzębska, Krzysztof Marciniec et al. · Pharmaceutics · 2021 · 59 citations · Full text

, , +17

Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects

Paweł Zajdel, Tomasz Kos, Krzysztof Marciniec et al. · European Journal of Medicinal Chemistry · 2018 · 47 citations · Full text

, , +10

1–5 of 27